Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gold River ProductionsGRPS -99.00% Equity-to-Asset is 0.49 as of Mar. 2096. Among 1,005 Drug Manufacturers companies, Gold River Productions ranks worse than 99502.39% on this metric.
The historical rank and industry rank for Gold River Productions's Equity-to-Asset or its related term are showing as below:
GRPS's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.6 * Ranked among companies with meaningful Equity-to-Asset only.
Gold River Productions (OTCPK:GRPS) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Gold River Productions Equity-to-Asset Related Terms
Gold River Productions Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Gold River Productions's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gold River Productions Equity-to-Asset Chart
Gold River Productions Annual Data
Trend
Mar92
Mar93
Mar94
Mar95
Equity-to-Asset
0.56
0.69
0.75
0.57
Gold River Productions Semi-Annual Data
Mar92
Mar93
Mar94
Mar95
Mar96
Equity-to-Asset
0.56
0.69
0.75
0.57
0.49
GRPS vs GCAN, STEK, KAYS: Equity-to-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Gold River Productions's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gold River Productions Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Gold River Productions's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Gold River Productions's Equity-to-Asset falls into.
Gold River Productions Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Gold River Productions's Equity to Asset Ratio for the fiscal year that ended in Mar. 2095 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gold River Productions (GRPS) has a Equity-to-Asset of 0.49 as of Mar. 2096. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Gold River Productions and its competitors. According to the industry distribution chart, Gold River Productions ranks #999999 out of 1005 companies in the Drug Manufacturers industry.
Is Gold River Productions' Equity-to-Asset too high?
Gold River Productions' current Equity-to-Asset is 0.49. The Drug Manufacturers industry median Equity-to-Asset is 0.60. Gold River Productions' value of 0.49 is 18.3% below this industry median. Based on the distribution chart, Gold River Productions ranks #999999 out of 1005 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Gold River Productions' Equity-to-Asset compare to GCAN and STEK?
According to the Drug Manufacturers industry distribution chart, Gold River Productions ranks #999999 out of 1005 companies for Equity-to-Asset. This places Gold River Productions in the lower half of its industry. The industry median Equity-to-Asset is 0.60. Gold River Productions' value of 0.49 is 18.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gold River Productions's current Equity-to-Asset of 0.49 is 18.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Gold River Productions and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gold River Productions's current Equity-to-Asset is 0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gold River Productions stock overvalued right now?
Gold River Productions (GRPS) has a current Equity-to-Asset of 0.49. The current Equity-to-Asset is 0.49 and 18.3% below the Drug Manufacturers industry median of 0.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Gold River Productions (GRPS), the current Equity-to-Asset is 0.49 as of Mar. 2096. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gold River Productions Inc is a medical cannabinoids company involved in developing products targeting disease states as supplements. The company offers various products, including Wrinkle Cream, EnergyPlex CBD, Hemorrhoid Plus CBD, Addiction Kit, and Sominoplex-CBD, among others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRPS has been successfully added to your 
